Music, Science, PARP And The Meaning Of A New Drug For Metastatic Breast Cancer With BRCA Mutations
So far, data from the OlympiAD trial for Lynparza in breast cancer are not impressive in a " Wow " kind of way. But the potential application of this, and other PARP inhibitors, is huge.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Source Type: news